The Federal Government, in collaboration with development partners and industry players, is advancing plans to boost local pharmaceutical manufacturing through the IMPACT Project.

This initiative, launched as a pilot in 2023, aims to build capacity for producing safe, high-quality medicines locally, enhancing health security and economic resilience.

Key investments include diagnostic test kit manufacturing in Ogun and Nasarawa, a technology transfer agreement with Bayer for family planning products in Anambra, and regulatory support from the World Bank and European Union.The project has trained over 100 scientists and professionals to support the sector's growth.Stakeholders emphasize the need for stronger research, quality regulation, and strategic partnerships to ensure sustainable development.

The move aligns with efforts to reduce reliance on imports and expand export opportunities, positioning Nigeria as a regional leader in pharmaceutical innovation.